| (2-Arylethenyl)-1, 3, 5-triazin-2-amines as a novel histamine H4 receptor ligands K Kamińska, J Ziemba, J Ner, JS Schwed, D Łażewska, M Więcek, ... European Journal of Medicinal Chemistry 103, 238-251, 2015 | 29 | 2015 |
| (Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors A Sasse, H Stark, X Ligneau, S Elz, S Reidemeister, CR Ganellin, ... Bioorganic & medicinal chemistry 8 (5), 1139-1149, 2000 | 7 | 2000 |
| (UN-) SUBSTITUTED ARYLTRIAZINE DERIVATIVES AS HISTAMINE H-4 RECEPTOR LIGANDS T Karcz, J Handzlik, J Ner, T Kottke, S Schwed, R Seifert, H Stark, ... INFLAMMATION RESEARCH 60, S355-S355, 2011 | | 2011 |
| [125I] iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor H Stark, K Purand, A Hüls, X Ligneau, M Garbarg, JC Schwartz, ... Journal of medicinal chemistry 39 (6), 1220-1226, 1996 | 84 | 1996 |
| [125I] iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. X Ligneau, M Garbarg, ML Vizuete, J Diaz, K Purand, H Stark, ... Journal of Pharmacology and Experimental Therapeutics 271 (1), 452-459, 1994 | 175 | 1994 |
| 0771 Pitolisant Is a Safe and Effective Treatment for Children with Prader-willi Syndrome (pws) LC Pullen, M Picone, L Tan, C Johnston, H Stark Sleep 42 (Supplement_1), A309-A310, 2019 | 5 | 2019 |
| 1-(3-{4-[(2, 4-Dinitroanilino) methyl] phenoxy} propyl) piperidinium chloride H Stark, M Amon, M Bolte Acta Crystallographica Section E: Structure Reports Online 63 (10), o4074-o4074, 2007 | | 2007 |
| 14 Histamine H3-Receptor H Stark, W Schunack Chemistry and Molecular Aspects of Drug Design and Action, 199, 2008 | | 2008 |
| 14 Histamine H3-Receptor Agonists and Antagonists: Chemical, Pharmacological H Stark, W Schunack CHEMISTRY AND MOLECULAR ASPECTS OF DRUG DESIGN AND ACTION, 199, 0 | | |
| 2-AMINO-4-(4-METHYLPIPERAZIN-1-YL)-1, 3, 5-TRIAZINE DERIVATIVES AS LIGANDS OF HISTAMINE H-4 RECEPTOR T Karcz, J Handzlik, D Lazewska, T Kottke, R Seifert, H Stark, ... INFLAMMATION RESEARCH 59, S351-S351, 2010 | | 2010 |
| 2, 4-Diaminopyrimidines as histamine H4 receptor ligands—Scaffold optimization and pharmacological characterization K Sander, T Kottke, Y Tanrikulu, E Proschak, L Weizel, EH Schneider, ... Bioorganic & medicinal chemistry 17 (20), 7186-7196, 2009 | 79 | 2009 |
| 261 Stimulation of the histamine 4 receptor increases the production of IL-5 in innate lymphoid cells K Schaper, H Stark, T Werfel, R Gutzmer Journal of Investigative Dermatology 136 (9), S205, 2016 | | 2016 |
| 4-(4-Chlorophenyl) thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition A Smelcerovic, A Zivkovic, BS Ilic, A Kolarevic, B Hofmann, D Steinhilber, ... Bioorganic Chemistry 95, 103528, 2020 | 17 | 2020 |
| 4-(ω-(Alkyloxy) alkyl)-1 H-imidazole Derivatives as Histamine H3 Receptor Antagonists/Agonists G Meier, M Krause, A Hüls, X Ligneau, HH Pertz, JM Arrang, CR Ganellin, ... Journal of medicinal chemistry 47 (10), 2678-2687, 2004 | 10 | 2004 |
| 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity M Krause, X Ligneau, H Stark, M Garbarg, JC Schwartz, W Schunack Journal of medicinal chemistry 41 (21), 4171-4176, 1998 | 33 | 1998 |
| 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases B Michalska, M Dzięgielewski, J Godyń, T Werner, M Bajda, T Karcz, ... ACS Chemical Neuroscience 15 (6), 1206-1218, 2024 | | 2024 |
| 5. Histamine receptor expression¶ Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class M Wiecek, K Kiec-Kononowicz, A Sasse, X Ligneau, JC Schwartz, ... Inflammation Research 51, S71, 2002 | | 2002 |
| 6 The Histamine H3 Receptor and its Ligands H Stark, JM Arrang, X Ligneau, M Garbarg, CR Ganellin, JC Schwartz, ... Progress in medicinal chemistry 38, 279-308, 2001 | 69 | 2001 |
| A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors B Hofmann, S Barzen, CB Rödl, A Kiehl, J Borig, A Zivkovic, H Stark, ... Journal of medicinal chemistry 54 (6), 1943-1947, 2011 | 46 | 2011 |
| A negative feedback loop regulates sphingosine kinase activity through sphingosine-1-phosphate (S1P) receptors B Linke, Y Schreiber, DD Zhang, O Coste, M Henke, J Fuchs, CD Schuh, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 383, 79-79, 2011 | | 2011 |
